Aptevo Therapeutics logo

Aptevo Therapeutics

APVO | NASDAQ
Chart Builder DCF Calculator
$0.55
-$0.04 (-7.42%)
At close: Nov 16, 2026, 4:00 PM ET
$0.55
$0.00 (-0.47%)
After-hours: Nov 16, 2026, 5:14 PM ET
-7.42%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
28
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #855/1021 (Top 84%)

Key Statistics

Market Data

Market Cap $1.2M
1D Range
0.55 0.61
52W Range
0.55 25.02

Valuation (TTM)

PE 0
PB 0.20
EV/EBITDA 0.17

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost in...

Sector Healthcare
Industry Biotechnology
Employees 33
IPO Date Jul 20, 2016
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.